Category: Pharmacokinetics
Highlights from HubXchange Immunotherapies Maryland 2024 Optimizing dose and leveraging biomarkers for enhanced patient safety in immunotherapy trials HubXchange Immunotherapies brought Read Now
Optimizing Outcomes with Pharmacokinetics (PK) Advancing Oncology Therapeutics Pharmacokinetic endpoints have always been important, but recent U.S. Food and Drug Read Now